Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extensive levamisole-induced vasculitis.
Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-Sallé D. Desvignes C, et al. Clin Exp Dermatol. 2017 Jun;42(4):413-415. doi: 10.1111/ced.13085. Epub 2017 Apr 10. Clin Exp Dermatol. 2017. PMID: 28397288
[Cutaneous leiomyomas and renal cancer].
Fialek M, Desvignes C, Levavasseur M, Lavogiez C, Staumont-Sallé D. Fialek M, et al. Among authors: desvignes c. Ann Dermatol Venereol. 2019 Mar;146(3):255-257. doi: 10.1016/j.annder.2018.09.598. Epub 2019 Jan 28. Ann Dermatol Venereol. 2019. PMID: 30704944 French. No abstract available.
Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction.
Krens LL, Baas JM, Verboom MC, Paintaud G, Desvignes C, Guchelaar HJ, Gelderblom H. Krens LL, et al. Among authors: desvignes c. Cancer Chemother Pharmacol. 2014 Jun;73(6):1303-6. doi: 10.1007/s00280-014-2462-4. Epub 2014 Apr 6. Cancer Chemother Pharmacol. 2014. PMID: 24705976 Free article.
Pharmacokinetics of adalimumab in Crohn's disease.
Ternant D, Karmiris K, Vermeire S, Desvignes C, Azzopardi N, Bejan-Angoulvant T, van Assche G, Paintaud G. Ternant D, et al. Among authors: desvignes c. Eur J Clin Pharmacol. 2015 Sep;71(9):1155-7. doi: 10.1007/s00228-015-1892-1. Epub 2015 Jun 27. Eur J Clin Pharmacol. 2015. PMID: 26115613 Free article. No abstract available.
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study.
Benhamou Y, Paintaud G, Azoulay E, Poullin P, Galicier L, Desvignes C, Baudel JL, Peltier J, Mira JP, Pène F, Presne C, Saheb S, Deligny C, Rousseau A, Féger F, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies. Benhamou Y, et al. Among authors: desvignes c. Am J Hematol. 2016 Dec;91(12):1246-1251. doi: 10.1002/ajh.24559. Epub 2016 Nov 8. Am J Hematol. 2016. PMID: 27643485 Free article. Clinical Trial.
69 results